Summary & Overview
HCPCS P9057: Frozen/Deglycerolized/Washed, Leukocyte-Reduced, Irradiated RBC Unit
HCPCS Level II code P9057 denotes a specialized red blood cell unit that has been frozen/deglycerolized or washed, leukocyte reduced and irradiated, billed per unit. These processed units are used when patients require blood components with minimized leukocyte content, removal of glycerol used in freezing, and inactivation of donor lymphocytes to reduce transfusion-related risks. Nationally, such products matter for complex transfusion needs in oncology, immunocompromised patients, and settings with heightened risk of transfusion-associated graft-versus-host disease.
Key payers commonly included in coverage analyses are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication provides a concise national overview of payment and clinical context: what the code represents, typical sites of service (hospital inpatient/outpatient and blood bank transfusion services), and how the product is used clinically.
Readers will find benchmarks and billing guidance content focused on claim line composition, common modifiers, and service line placement where available, as well as policy and coding considerations relevant to complex blood product billing. Where specific payer policy details, taxonomies, or ICD-10 pairing data are not provided in the input, the report notes that such fields are not available and directs readers to payer manuals for plan-specific rules.
Billing Code Overview
HCPCS Level II code P9057 describes red blood cells that have been frozen, deglycerolized or washed, leukocytes reduced, and irradiated, billed per unit. The service type is transfusion of specially processed red blood cell units prepared to reduce leukocyte content, remove cryoprotectant agents, and inactivate lymphocytes via irradiation. The typical site of service for this product is hospital inpatient or hospital outpatient settings, including blood banks and transfusion services where specialized blood component processing and administration occur.
Clinical & Coding Specifications
Clinical Context
A hospitalized adult patient with a history of sickle cell disease presents with acute chest syndrome requiring transfusion. The transfusion service prepares P9057 — a unit of red blood cells that has been frozen/deglycerolized/washed, leukocyte reduced, and irradiated — for administration to reduce alloimmunization risk and prevent transfusion-associated graft-versus-host disease. The clinical workflow: ordering clinician selects compatible, specially processed RBCs in the electronic medical record; the blood bank verifies crossmatch and special processing requirements; units are thawed/deglycerolized and washed, leukoreduced and irradiated per institutional protocol; bedside verification and informed consent occur; transfusion is administered in the inpatient ward or intensive care unit with vital sign monitoring; transfusion reaction surveillance and documentation follow hospital transfusion service policies.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier | Use when no specific modifier applies to the service |
22 | Increased procedural services |